The Latest Breaking News from Labcorp

Due to Labcorp Holdings' outperformance relative to the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Labcorp Holdings will release its first-quarter earnings later this month, and analysts anticipate a single-digit bottom-line growth.

Labcorp Holdings recently outperformed the healthcare sector peers, and Wall Street analysts are moderately optimistic about the stock’s prospects.

With Labcorp Holdings gearing up to release its second-quarter earnings results next month, analysts project a double-digit earnings growth.

At least one in 20 people who are pregnant develop a scary complication called preeclampsia, a high blood pressure disorder that kills 70,000 women and 500,000 babies worldwide every year

LOS ANGELES — On Nov. 1, Kate Manriquez, whose first child is due in May, did what many women do a couple months into their pregnancies: She gave a blood sample at her doctor's office for a genetic test meant to help detect birth defects. More than a month later,…

Laboratory Corporation of America Holdings (NYSE: LH), also known as LabCorp, is slated to report second-quarter 2022 results on Jul 28, before market open.

The Biden administration has started shipping testing kits for monkeypox to commercial laboratories, in a bid to speed diagnostic tests for suspected infections for the virus that has already infected at least 142 people in the U.S. The Centers for Disease Control and Prevention is sending tests to commercial labs,…

The FDA has authorized the first nonprescription test to detect Covid-19, influenza, and respiratory syncytial virus (RSV). The test, called the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test, was developed by Laboratory Corp of America Holdings (NYSE:LH). It can be sold directly to consumers online or at retail.  A person can self-collect a nasal…